Novel Approaches to Assessing Cardiac Safety —Proceedings of a Workshop

1 University of Oxford, Oxford, UK2 Member of the preDiCT Scientific Advisory Board, University of Oxford, Oxford, UK3 Rashmi Shah Consultancy Ltd, Gerrards Cross, UK4 Proteus Associates, Oxford, UK5 Tobin Consulting LLC, Newtown Square, Pennsylvania, USA6 I3BH-Universitat Polite`cnica de Vale`ncia, Valencia, Spain

[1]  C. S. James,et al.  Additional reading material , 1995 .

[2]  Gary R. Mirams,et al.  Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk , 2011, Cardiovascular research.

[3]  M. Fink,et al.  Multiscale modelling of drug-induced effects on cardiac electrophysiological activity. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[4]  Miguel O. Bernabeu,et al.  Simulating Drug-Induced Effects on the Heart: From Ion Channel to Body Surface Electrocardiogram , 2011, FIMH.

[5]  P. Laguna,et al.  Mechanisms of Ventricular Rate Adaptation as a Predictor of Arrhythmic Risk Computer Modeling and Simulation Characterization of Ventricular Hr Adaptation Dynamics Evaluation of Proarrhythmic Risk in Simulation , 2022 .

[6]  A. Corrias,et al.  Arrhythmic risk biomarkers for the assessment of drug cardiotoxicity: from experiments to computer simulations , 2010, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.

[7]  Javier Saiz,et al.  Effects of the Antiarrhythmic Drug Dofetilide on Transmural Dispersion of Repolarization in Ventriculum. A Computer Modeling Study , 2011, IEEE Transactions on Biomedical Engineering.

[8]  K. Burrage,et al.  The Systems Biology Approach to Drug Development: Application to Toxicity Assessment of Cardiac Drugs , 2010, Clinical pharmacology and therapeutics.

[9]  Innovation OR Stagnation.  Challenge and Opportunity on the Critical Path to New Medical Products , 2004 .